Last edition
News about "Santhera Pharmaceuticals "
Santhera Expands Agamree Distribution Partnership with Biomedica Across Five Additional Markets
Santhera Pharmaceuticals has expanded its exclusive distribution partnership with Biomedica to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, extending access to Agamree (vamorolone) for patients with Duchenne muscular dystrophy across additional underserved markets.
Santhera Pharmaceuticals | 14/07/2026 | By News Bureau
Santhera Partners with Ikris Pharma Network for Distribution of AGAMREE in India
Swiss specialty pharma company Santhera Pharmaceuticals has entered into an exclusive agreement with Ikris Pharma Network to distribute AGAMREE (vamorolone) in India for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above.
Santhera Pharmaceuticals | 29/08/2025 | By Dineshwori | 458
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy